Fortrea will become the new brand identity for Labcorp's Clinical Development business in connection with the spin-off from Labcorp, which is expected in mid-2023. As a provider of phase I-IV clinical trial management, regulatory guidance, patient access solutions and market access consulting, Fortrea will partner with both emerging and large pharmaceutical, biotechnology, device and diagnostic companies to drive healthcare innovation and improve the lives of patients worldwide. Learn more at Fortrea.com